Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Colorcon
Moodys
McKesson
Express Scripts

Last Updated: January 24, 2022

Volunteer for clinical trials for dronabinol at ClinicalTrialExchange

DrugPatentWatch Database Preview

Dronabinol - Generic Drug Details

➤ Subscribe for complete access

« Back to Dashboard

What are the generic sources for dronabinol and what is the scope of freedom to operate?

Dronabinol is the generic ingredient in three branded drugs marketed by Akorn, Ascent Pharms Inc, Insys Therap, Lannett Co Inc, Svc Pharma, Alkem Labs Ltd, and Benuvia, and is included in seven NDAs. There are three patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Dronabinol has four patent family members in four countries.

There are eleven drug master file entries for dronabinol. Eleven suppliers are listed for this compound.

Drug Prices for dronabinol

See drug prices for dronabinol

Recent Clinical Trials for dronabinol

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Canopy Growth CorporationPhase 1
Johns Hopkins UniversityPhase 1
University of California, San DiegoEarly Phase 1

See all dronabinol clinical trials

Pharmacology for dronabinol
Drug ClassCannabinoid
Medical Subject Heading (MeSH) Categories for dronabinol
Paragraph IV (Patent) Challenges for DRONABINOL
Tradename Dosage Ingredient NDA Submissiondate
SYNDROS SOLUTION;ORAL dronabinol 205525 2017-04-17

US Patents and Regulatory Information for dronabinol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Benuvia SYNDROS dronabinol SOLUTION;ORAL 205525-001 Mar 23, 2017 RX Yes Yes ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial Y Y ⤷  Sign up for a Free Trial
Lannett Co Inc DRONABINOL dronabinol CAPSULE;ORAL 201463-002 May 18, 2018 AB RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Alkem Labs Ltd MARINOL dronabinol CAPSULE;ORAL 018651-002 May 31, 1985 AB RX Yes Yes ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Akorn DRONABINOL dronabinol CAPSULE;ORAL 079217-003 Jun 20, 2014 AB RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Lannett Co Inc DRONABINOL dronabinol CAPSULE;ORAL 201463-001 May 18, 2018 AB RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Svc Pharma DRONABINOL dronabinol CAPSULE;ORAL 078292-002 Jun 27, 2008 AB RX No No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for dronabinol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alkem Labs Ltd MARINOL dronabinol CAPSULE;ORAL 018651-001 May 31, 1985 ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Alkem Labs Ltd MARINOL dronabinol CAPSULE;ORAL 018651-002 May 31, 1985 ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
Alkem Labs Ltd MARINOL dronabinol CAPSULE;ORAL 018651-003 May 31, 1985 ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Dow
Colorcon
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.